nodes	percent_of_prediction	percent_of_DWPC	metapath
Prochlorperazine—breast cancer—Estradiol—osteoporosis	0.282	0.363	CpDpCtD
Prochlorperazine—breast cancer—Conjugated Estrogens—osteoporosis	0.282	0.363	CpDpCtD
Prochlorperazine—breast cancer—Ethinyl Estradiol—osteoporosis	0.213	0.275	CpDpCtD
Prochlorperazine—CYP3A4—Estropipate—osteoporosis	0.0193	0.158	CbGbCtD
Prochlorperazine—CYP3A4—Calcitriol—osteoporosis	0.0193	0.158	CbGbCtD
Prochlorperazine—CYP2D6—Cholecalciferol—osteoporosis	0.0157	0.128	CbGbCtD
Prochlorperazine—CYP3A4—Ergocalciferol—osteoporosis	0.0155	0.126	CbGbCtD
Prochlorperazine—CYP3A4—Raloxifene—osteoporosis	0.0129	0.105	CbGbCtD
Prochlorperazine—CYP3A4—Ethinyl Estradiol—osteoporosis	0.0125	0.102	CbGbCtD
Prochlorperazine—CYP3A4—Cholecalciferol—osteoporosis	0.00997	0.0815	CbGbCtD
Prochlorperazine—CYP3A4—Conjugated Estrogens—osteoporosis	0.00915	0.0748	CbGbCtD
Prochlorperazine—CYP3A4—Estradiol—osteoporosis	0.00803	0.0657	CbGbCtD
Prochlorperazine—Asthma—Zoledronate—osteoporosis	0.000299	0.00297	CcSEcCtD
Prochlorperazine—Dysphagia—Zoledronate—osteoporosis	0.000299	0.00297	CcSEcCtD
Prochlorperazine—Influenza—Zoledronate—osteoporosis	0.000299	0.00297	CcSEcCtD
Prochlorperazine—Eczema—Estradiol—osteoporosis	0.000297	0.00295	CcSEcCtD
Prochlorperazine—Nervousness—Estropipate—osteoporosis	0.000295	0.00293	CcSEcCtD
Prochlorperazine—Nasal congestion—Estradiol—osteoporosis	0.000293	0.00291	CcSEcCtD
Prochlorperazine—Arrhythmia—Calcitriol—osteoporosis	0.000293	0.0029	CcSEcCtD
Prochlorperazine—Muscle spasms—Estropipate—osteoporosis	0.000292	0.0029	CcSEcCtD
Prochlorperazine—Erythema—Ibandronate—osteoporosis	0.000291	0.00289	CcSEcCtD
Prochlorperazine—Dizziness—Calcium Acetate—osteoporosis	0.000289	0.00286	CcSEcCtD
Prochlorperazine—Influenza—Conjugated Estrogens—osteoporosis	0.000288	0.00286	CcSEcCtD
Prochlorperazine—Dysphagia—Conjugated Estrogens—osteoporosis	0.000288	0.00286	CcSEcCtD
Prochlorperazine—Asthma—Conjugated Estrogens—osteoporosis	0.000288	0.00286	CcSEcCtD
Prochlorperazine—Muscle spasms—Alendronate—osteoporosis	0.000288	0.00285	CcSEcCtD
Prochlorperazine—Erythema—Calcitriol—osteoporosis	0.000285	0.00283	CcSEcCtD
Prochlorperazine—Infection—Etidronic acid—osteoporosis	0.000285	0.00282	CcSEcCtD
Prochlorperazine—Pancytopenia—Zoledronate—osteoporosis	0.000284	0.00282	CcSEcCtD
Prochlorperazine—Increased appetite—Estradiol—osteoporosis	0.000284	0.00282	CcSEcCtD
Prochlorperazine—Muscle spasms—Raloxifene—osteoporosis	0.000283	0.00281	CcSEcCtD
Prochlorperazine—Muscle spasms—Ibandronate—osteoporosis	0.00028	0.00278	CcSEcCtD
Prochlorperazine—Angioedema—Estropipate—osteoporosis	0.000278	0.00275	CcSEcCtD
Prochlorperazine—Anaphylactoid reaction—Estradiol—osteoporosis	0.000276	0.00273	CcSEcCtD
Prochlorperazine—Angioedema—Alendronate—osteoporosis	0.000273	0.00271	CcSEcCtD
Prochlorperazine—Agranulocytosis—Pamidronate—osteoporosis	0.000273	0.0027	CcSEcCtD
Prochlorperazine—Weight increased—Zoledronate—osteoporosis	0.000272	0.0027	CcSEcCtD
Prochlorperazine—Oedema peripheral—Risedronate—osteoporosis	0.000272	0.0027	CcSEcCtD
Prochlorperazine—Erythema multiforme—Ethinyl Estradiol—osteoporosis	0.000268	0.00265	CcSEcCtD
Prochlorperazine—Angioedema—Ibandronate—osteoporosis	0.000266	0.00264	CcSEcCtD
Prochlorperazine—Cough—Estropipate—osteoporosis	0.000265	0.00263	CcSEcCtD
Prochlorperazine—Weight increased—Conjugated Estrogens—osteoporosis	0.000262	0.0026	CcSEcCtD
Prochlorperazine—Agitation—Calcitriol—osteoporosis	0.000262	0.0026	CcSEcCtD
Prochlorperazine—Hyperglycaemia—Conjugated Estrogens—osteoporosis	0.00026	0.00258	CcSEcCtD
Prochlorperazine—Cough—Raloxifene—osteoporosis	0.000257	0.00255	CcSEcCtD
Prochlorperazine—Agranulocytosis—Zoledronate—osteoporosis	0.000249	0.00247	CcSEcCtD
Prochlorperazine—Oedema—Estropipate—osteoporosis	0.000248	0.00246	CcSEcCtD
Prochlorperazine—Anaphylactic shock—Estropipate—osteoporosis	0.000248	0.00246	CcSEcCtD
Prochlorperazine—Convulsion—Calcitriol—osteoporosis	0.000247	0.00245	CcSEcCtD
Prochlorperazine—Arrhythmia—Risedronate—osteoporosis	0.000246	0.00244	CcSEcCtD
Prochlorperazine—Infection—Estropipate—osteoporosis	0.000246	0.00244	CcSEcCtD
Prochlorperazine—Constipation—Etidronic acid—osteoporosis	0.000245	0.00243	CcSEcCtD
Prochlorperazine—Infection—Alendronate—osteoporosis	0.000243	0.00241	CcSEcCtD
Prochlorperazine—Dry mouth—Ibandronate—osteoporosis	0.000243	0.00241	CcSEcCtD
Prochlorperazine—Skin disorder—Estropipate—osteoporosis	0.000241	0.00239	CcSEcCtD
Prochlorperazine—Infection—Raloxifene—osteoporosis	0.000239	0.00237	CcSEcCtD
Prochlorperazine—Anaphylactic shock—Ibandronate—osteoporosis	0.000238	0.00236	CcSEcCtD
Prochlorperazine—Dry mouth—Calcitriol—osteoporosis	0.000238	0.00236	CcSEcCtD
Prochlorperazine—Muscle spasms—Ethinyl Estradiol—osteoporosis	0.000237	0.00235	CcSEcCtD
Prochlorperazine—Infection—Ibandronate—osteoporosis	0.000236	0.00234	CcSEcCtD
Prochlorperazine—Oedema peripheral—Zoledronate—osteoporosis	0.000236	0.00234	CcSEcCtD
Prochlorperazine—Thrombocytopenia—Raloxifene—osteoporosis	0.000235	0.00233	CcSEcCtD
Prochlorperazine—Skin disorder—Raloxifene—osteoporosis	0.000233	0.00231	CcSEcCtD
Prochlorperazine—Anaphylactic shock—Calcitriol—osteoporosis	0.000233	0.00231	CcSEcCtD
Prochlorperazine—Skin disorder—Ibandronate—osteoporosis	0.000231	0.00229	CcSEcCtD
Prochlorperazine—Muscle spasms—Risedronate—osteoporosis	0.000231	0.00229	CcSEcCtD
Prochlorperazine—Asthma—Estradiol—osteoporosis	0.000231	0.00229	CcSEcCtD
Prochlorperazine—Dysphagia—Estradiol—osteoporosis	0.000231	0.00229	CcSEcCtD
Prochlorperazine—Influenza—Estradiol—osteoporosis	0.000231	0.00229	CcSEcCtD
Prochlorperazine—Erythema—Pamidronate—osteoporosis	0.000228	0.00226	CcSEcCtD
Prochlorperazine—Urticaria—Etidronic acid—osteoporosis	0.000228	0.00226	CcSEcCtD
Prochlorperazine—Oedema peripheral—Conjugated Estrogens—osteoporosis	0.000227	0.00225	CcSEcCtD
Prochlorperazine—Skin disorder—Calcitriol—osteoporosis	0.000226	0.00224	CcSEcCtD
Prochlorperazine—Angioedema—Ethinyl Estradiol—osteoporosis	0.000225	0.00223	CcSEcCtD
Prochlorperazine—Insomnia—Estropipate—osteoporosis	0.000224	0.00222	CcSEcCtD
Prochlorperazine—Nervousness—Pamidronate—osteoporosis	0.000222	0.0022	CcSEcCtD
Prochlorperazine—Somnolence—Estropipate—osteoporosis	0.00022	0.00219	CcSEcCtD
Prochlorperazine—Muscle spasms—Pamidronate—osteoporosis	0.000219	0.00218	CcSEcCtD
Prochlorperazine—Angioedema—Risedronate—osteoporosis	0.000219	0.00218	CcSEcCtD
Prochlorperazine—Erythema multiforme—Conjugated Estrogens—osteoporosis	0.000218	0.00216	CcSEcCtD
Prochlorperazine—Insomnia—Raloxifene—osteoporosis	0.000217	0.00216	CcSEcCtD
Prochlorperazine—Insomnia—Ibandronate—osteoporosis	0.000215	0.00213	CcSEcCtD
Prochlorperazine—Cough—Ethinyl Estradiol—osteoporosis	0.000215	0.00213	CcSEcCtD
Prochlorperazine—Arrhythmia—Zoledronate—osteoporosis	0.000214	0.00212	CcSEcCtD
Prochlorperazine—Constipation—Estropipate—osteoporosis	0.000212	0.0021	CcSEcCtD
Prochlorperazine—Hypersensitivity—Etidronic acid—osteoporosis	0.000211	0.00209	CcSEcCtD
Prochlorperazine—Insomnia—Calcitriol—osteoporosis	0.000211	0.00209	CcSEcCtD
Prochlorperazine—Photosensitivity reaction—Estradiol—osteoporosis	0.000211	0.00209	CcSEcCtD
Prochlorperazine—Weight increased—Estradiol—osteoporosis	0.00021	0.00208	CcSEcCtD
Prochlorperazine—Agitation—Pamidronate—osteoporosis	0.00021	0.00208	CcSEcCtD
Prochlorperazine—Cough—Risedronate—osteoporosis	0.00021	0.00208	CcSEcCtD
Prochlorperazine—Constipation—Alendronate—osteoporosis	0.000209	0.00207	CcSEcCtD
Prochlorperazine—Angioedema—Pamidronate—osteoporosis	0.000209	0.00207	CcSEcCtD
Prochlorperazine—Erythema—Zoledronate—osteoporosis	0.000209	0.00207	CcSEcCtD
Prochlorperazine—Hyperglycaemia—Estradiol—osteoporosis	0.000208	0.00206	CcSEcCtD
Prochlorperazine—Somnolence—Calcitriol—osteoporosis	0.000207	0.00205	CcSEcCtD
Prochlorperazine—Arrhythmia—Conjugated Estrogens—osteoporosis	0.000206	0.00204	CcSEcCtD
Prochlorperazine—Leukopenia—Pamidronate—osteoporosis	0.000204	0.00203	CcSEcCtD
Prochlorperazine—Constipation—Ibandronate—osteoporosis	0.000203	0.00202	CcSEcCtD
Prochlorperazine—Pruritus—Etidronic acid—osteoporosis	0.000203	0.00201	CcSEcCtD
Prochlorperazine—Oedema—Ethinyl Estradiol—osteoporosis	0.000201	0.00199	CcSEcCtD
Prochlorperazine—Erythema—Conjugated Estrogens—osteoporosis	0.000201	0.00199	CcSEcCtD
Prochlorperazine—Muscle spasms—Zoledronate—osteoporosis	0.0002	0.00199	CcSEcCtD
Prochlorperazine—Jaundice—Estradiol—osteoporosis	0.0002	0.00199	CcSEcCtD
Prochlorperazine—Dry mouth—Risedronate—osteoporosis	0.0002	0.00198	CcSEcCtD
Prochlorperazine—Infection—Ethinyl Estradiol—osteoporosis	0.0002	0.00198	CcSEcCtD
Prochlorperazine—Cough—Pamidronate—osteoporosis	0.000199	0.00198	CcSEcCtD
Prochlorperazine—Constipation—Calcitriol—osteoporosis	0.000199	0.00197	CcSEcCtD
Prochlorperazine—Convulsion—Pamidronate—osteoporosis	0.000198	0.00196	CcSEcCtD
Prochlorperazine—Urticaria—Estropipate—osteoporosis	0.000197	0.00195	CcSEcCtD
Prochlorperazine—Vision blurred—Zoledronate—osteoporosis	0.000197	0.00195	CcSEcCtD
Prochlorperazine—Body temperature increased—Estropipate—osteoporosis	0.000196	0.00194	CcSEcCtD
Prochlorperazine—Tremor—Zoledronate—osteoporosis	0.000195	0.00194	CcSEcCtD
Prochlorperazine—Skin disorder—Ethinyl Estradiol—osteoporosis	0.000195	0.00194	CcSEcCtD
Prochlorperazine—Nervousness—Conjugated Estrogens—osteoporosis	0.000195	0.00193	CcSEcCtD
Prochlorperazine—Infection—Risedronate—osteoporosis	0.000195	0.00193	CcSEcCtD
Prochlorperazine—Urticaria—Alendronate—osteoporosis	0.000194	0.00192	CcSEcCtD
Prochlorperazine—Body temperature increased—Alendronate—osteoporosis	0.000193	0.00192	CcSEcCtD
Prochlorperazine—Muscle spasms—Conjugated Estrogens—osteoporosis	0.000193	0.00191	CcSEcCtD
Prochlorperazine—Agitation—Zoledronate—osteoporosis	0.000192	0.0019	CcSEcCtD
Prochlorperazine—Angioedema—Zoledronate—osteoporosis	0.000191	0.00189	CcSEcCtD
Prochlorperazine—Skin disorder—Risedronate—osteoporosis	0.00019	0.00189	CcSEcCtD
Prochlorperazine—Body temperature increased—Raloxifene—osteoporosis	0.00019	0.00188	CcSEcCtD
Prochlorperazine—Vision blurred—Conjugated Estrogens—osteoporosis	0.000189	0.00188	CcSEcCtD
Prochlorperazine—Urticaria—Ibandronate—osteoporosis	0.000189	0.00187	CcSEcCtD
Prochlorperazine—Body temperature increased—Ibandronate—osteoporosis	0.000188	0.00186	CcSEcCtD
Prochlorperazine—Leukopenia—Zoledronate—osteoporosis	0.000187	0.00185	CcSEcCtD
Prochlorperazine—Oedema—Pamidronate—osteoporosis	0.000186	0.00185	CcSEcCtD
Prochlorperazine—Anaphylactic shock—Pamidronate—osteoporosis	0.000186	0.00185	CcSEcCtD
Prochlorperazine—Infection—Pamidronate—osteoporosis	0.000185	0.00184	CcSEcCtD
Prochlorperazine—Urticaria—Calcitriol—osteoporosis	0.000185	0.00183	CcSEcCtD
Prochlorperazine—Body temperature increased—Calcitriol—osteoporosis	0.000184	0.00183	CcSEcCtD
Prochlorperazine—Angioedema—Conjugated Estrogens—osteoporosis	0.000183	0.00182	CcSEcCtD
Prochlorperazine—Hypersensitivity—Estropipate—osteoporosis	0.000183	0.00181	CcSEcCtD
Prochlorperazine—Thrombocytopenia—Pamidronate—osteoporosis	0.000182	0.00181	CcSEcCtD
Prochlorperazine—Cough—Zoledronate—osteoporosis	0.000182	0.0018	CcSEcCtD
Prochlorperazine—Oedema peripheral—Estradiol—osteoporosis	0.000182	0.0018	CcSEcCtD
Prochlorperazine—Rash—Etidronic acid—osteoporosis	0.000181	0.00179	CcSEcCtD
Prochlorperazine—Convulsion—Zoledronate—osteoporosis	0.000181	0.00179	CcSEcCtD
Prochlorperazine—Dermatitis—Etidronic acid—osteoporosis	0.000181	0.00179	CcSEcCtD
Prochlorperazine—Hypersensitivity—Alendronate—osteoporosis	0.00018	0.00178	CcSEcCtD
Prochlorperazine—Headache—Etidronic acid—osteoporosis	0.00018	0.00178	CcSEcCtD
Prochlorperazine—Insomnia—Risedronate—osteoporosis	0.000177	0.00176	CcSEcCtD
Prochlorperazine—Pruritus—Estropipate—osteoporosis	0.000175	0.00174	CcSEcCtD
Prochlorperazine—Hypersensitivity—Ibandronate—osteoporosis	0.000175	0.00174	CcSEcCtD
Prochlorperazine—Cough—Conjugated Estrogens—osteoporosis	0.000175	0.00174	CcSEcCtD
Prochlorperazine—Dyspnoea—Risedronate—osteoporosis	0.000175	0.00173	CcSEcCtD
Prochlorperazine—Erythema multiforme—Estradiol—osteoporosis	0.000175	0.00173	CcSEcCtD
Prochlorperazine—Hypotension—Pamidronate—osteoporosis	0.000174	0.00173	CcSEcCtD
Prochlorperazine—Convulsion—Conjugated Estrogens—osteoporosis	0.000174	0.00173	CcSEcCtD
Prochlorperazine—Dry mouth—Zoledronate—osteoporosis	0.000174	0.00172	CcSEcCtD
Prochlorperazine—Pruritus—Alendronate—osteoporosis	0.000173	0.00171	CcSEcCtD
Prochlorperazine—Constipation—Ethinyl Estradiol—osteoporosis	0.000172	0.0017	CcSEcCtD
Prochlorperazine—Hypersensitivity—Calcitriol—osteoporosis	0.000172	0.0017	CcSEcCtD
Prochlorperazine—Anaphylactic shock—Zoledronate—osteoporosis	0.00017	0.00169	CcSEcCtD
Prochlorperazine—Oedema—Zoledronate—osteoporosis	0.00017	0.00169	CcSEcCtD
Prochlorperazine—Infection—Zoledronate—osteoporosis	0.000169	0.00168	CcSEcCtD
Prochlorperazine—Insomnia—Pamidronate—osteoporosis	0.000169	0.00167	CcSEcCtD
Prochlorperazine—Pruritus—Ibandronate—osteoporosis	0.000168	0.00167	CcSEcCtD
Prochlorperazine—Constipation—Risedronate—osteoporosis	0.000168	0.00166	CcSEcCtD
Prochlorperazine—Thrombocytopenia—Zoledronate—osteoporosis	0.000167	0.00165	CcSEcCtD
Prochlorperazine—Dyspnoea—Pamidronate—osteoporosis	0.000166	0.00165	CcSEcCtD
Prochlorperazine—Somnolence—Pamidronate—osteoporosis	0.000166	0.00164	CcSEcCtD
Prochlorperazine—Skin disorder—Zoledronate—osteoporosis	0.000165	0.00164	CcSEcCtD
Prochlorperazine—Pruritus—Calcitriol—osteoporosis	0.000165	0.00163	CcSEcCtD
Prochlorperazine—Dizziness—Estropipate—osteoporosis	0.000164	0.00163	CcSEcCtD
Prochlorperazine—Oedema—Conjugated Estrogens—osteoporosis	0.000164	0.00163	CcSEcCtD
Prochlorperazine—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.000164	0.00163	CcSEcCtD
Prochlorperazine—Infection—Conjugated Estrogens—osteoporosis	0.000163	0.00161	CcSEcCtD
Prochlorperazine—Dizziness—Alendronate—osteoporosis	0.000162	0.0016	CcSEcCtD
Prochlorperazine—Erythema—Estradiol—osteoporosis	0.000161	0.00159	CcSEcCtD
Prochlorperazine—Urticaria—Ethinyl Estradiol—osteoporosis	0.00016	0.00158	CcSEcCtD
Prochlorperazine—Constipation—Pamidronate—osteoporosis	0.000159	0.00158	CcSEcCtD
Prochlorperazine—Skin disorder—Conjugated Estrogens—osteoporosis	0.000159	0.00158	CcSEcCtD
Prochlorperazine—Hypotension—Zoledronate—osteoporosis	0.000159	0.00158	CcSEcCtD
Prochlorperazine—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000159	0.00158	CcSEcCtD
Prochlorperazine—Dizziness—Raloxifene—osteoporosis	0.000159	0.00158	CcSEcCtD
Prochlorperazine—Dizziness—Ibandronate—osteoporosis	0.000157	0.00156	CcSEcCtD
Prochlorperazine—Rash—Estropipate—osteoporosis	0.000156	0.00155	CcSEcCtD
Prochlorperazine—Dermatitis—Estropipate—osteoporosis	0.000156	0.00155	CcSEcCtD
Prochlorperazine—Nervousness—Estradiol—osteoporosis	0.000156	0.00155	CcSEcCtD
Prochlorperazine—Urticaria—Risedronate—osteoporosis	0.000156	0.00154	CcSEcCtD
Prochlorperazine—Headache—Estropipate—osteoporosis	0.000155	0.00154	CcSEcCtD
Prochlorperazine—Body temperature increased—Risedronate—osteoporosis	0.000155	0.00154	CcSEcCtD
Prochlorperazine—Muscle spasms—Estradiol—osteoporosis	0.000155	0.00153	CcSEcCtD
Prochlorperazine—Rash—Alendronate—osteoporosis	0.000154	0.00153	CcSEcCtD
Prochlorperazine—Insomnia—Zoledronate—osteoporosis	0.000154	0.00153	CcSEcCtD
Prochlorperazine—Dermatitis—Alendronate—osteoporosis	0.000154	0.00153	CcSEcCtD
Prochlorperazine—Hypotension—Conjugated Estrogens—osteoporosis	0.000153	0.00152	CcSEcCtD
Prochlorperazine—Headache—Alendronate—osteoporosis	0.000153	0.00152	CcSEcCtD
Prochlorperazine—Dyspnoea—Zoledronate—osteoporosis	0.000152	0.0015	CcSEcCtD
Prochlorperazine—Rash—Raloxifene—osteoporosis	0.000151	0.0015	CcSEcCtD
Prochlorperazine—Dermatitis—Raloxifene—osteoporosis	0.000151	0.0015	CcSEcCtD
Prochlorperazine—Somnolence—Zoledronate—osteoporosis	0.000151	0.0015	CcSEcCtD
Prochlorperazine—Tremor—Estradiol—osteoporosis	0.000151	0.00149	CcSEcCtD
Prochlorperazine—Headache—Raloxifene—osteoporosis	0.000151	0.00149	CcSEcCtD
Prochlorperazine—Rash—Ibandronate—osteoporosis	0.00015	0.00149	CcSEcCtD
Prochlorperazine—Dermatitis—Ibandronate—osteoporosis	0.00015	0.00149	CcSEcCtD
Prochlorperazine—Headache—Ibandronate—osteoporosis	0.000149	0.00148	CcSEcCtD
Prochlorperazine—Insomnia—Conjugated Estrogens—osteoporosis	0.000148	0.00147	CcSEcCtD
Prochlorperazine—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000148	0.00147	CcSEcCtD
Prochlorperazine—Agitation—Estradiol—osteoporosis	0.000148	0.00146	CcSEcCtD
Prochlorperazine—Body temperature increased—Pamidronate—osteoporosis	0.000147	0.00146	CcSEcCtD
Prochlorperazine—Angioedema—Estradiol—osteoporosis	0.000147	0.00146	CcSEcCtD
Prochlorperazine—Rash—Calcitriol—osteoporosis	0.000147	0.00146	CcSEcCtD
Prochlorperazine—Dermatitis—Calcitriol—osteoporosis	0.000147	0.00145	CcSEcCtD
Prochlorperazine—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000146	0.00145	CcSEcCtD
Prochlorperazine—Headache—Calcitriol—osteoporosis	0.000146	0.00145	CcSEcCtD
Prochlorperazine—Somnolence—Conjugated Estrogens—osteoporosis	0.000146	0.00144	CcSEcCtD
Prochlorperazine—Constipation—Zoledronate—osteoporosis	0.000146	0.00144	CcSEcCtD
Prochlorperazine—Hypersensitivity—Risedronate—osteoporosis	0.000144	0.00143	CcSEcCtD
Prochlorperazine—Pruritus—Ethinyl Estradiol—osteoporosis	0.000142	0.00141	CcSEcCtD
Prochlorperazine—Cough—Estradiol—osteoporosis	0.00014	0.00139	CcSEcCtD
Prochlorperazine—Constipation—Conjugated Estrogens—osteoporosis	0.00014	0.00139	CcSEcCtD
Prochlorperazine—Pruritus—Risedronate—osteoporosis	0.000139	0.00138	CcSEcCtD
Prochlorperazine—Hypersensitivity—Pamidronate—osteoporosis	0.000137	0.00136	CcSEcCtD
Prochlorperazine—Urticaria—Zoledronate—osteoporosis	0.000135	0.00134	CcSEcCtD
Prochlorperazine—Body temperature increased—Zoledronate—osteoporosis	0.000135	0.00133	CcSEcCtD
Prochlorperazine—Dry mouth—Estradiol—osteoporosis	0.000134	0.00133	CcSEcCtD
Prochlorperazine—Dizziness—Ethinyl Estradiol—osteoporosis	0.000133	0.00132	CcSEcCtD
Prochlorperazine—Pruritus—Pamidronate—osteoporosis	0.000132	0.00131	CcSEcCtD
Prochlorperazine—Anaphylactic shock—Estradiol—osteoporosis	0.000131	0.0013	CcSEcCtD
Prochlorperazine—Oedema—Estradiol—osteoporosis	0.000131	0.0013	CcSEcCtD
Prochlorperazine—Infection—Estradiol—osteoporosis	0.00013	0.00129	CcSEcCtD
Prochlorperazine—Urticaria—Conjugated Estrogens—osteoporosis	0.00013	0.00129	CcSEcCtD
Prochlorperazine—Dizziness—Risedronate—osteoporosis	0.00013	0.00129	CcSEcCtD
Prochlorperazine—Body temperature increased—Conjugated Estrogens—osteoporosis	0.00013	0.00128	CcSEcCtD
Prochlorperazine—Skin disorder—Estradiol—osteoporosis	0.000127	0.00126	CcSEcCtD
Prochlorperazine—Rash—Ethinyl Estradiol—osteoporosis	0.000127	0.00126	CcSEcCtD
Prochlorperazine—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000127	0.00126	CcSEcCtD
Prochlorperazine—Headache—Ethinyl Estradiol—osteoporosis	0.000126	0.00125	CcSEcCtD
Prochlorperazine—Hypersensitivity—Zoledronate—osteoporosis	0.000125	0.00124	CcSEcCtD
Prochlorperazine—Rash—Risedronate—osteoporosis	0.000124	0.00123	CcSEcCtD
Prochlorperazine—Dermatitis—Risedronate—osteoporosis	0.000123	0.00122	CcSEcCtD
Prochlorperazine—Dizziness—Pamidronate—osteoporosis	0.000123	0.00122	CcSEcCtD
Prochlorperazine—Headache—Risedronate—osteoporosis	0.000123	0.00122	CcSEcCtD
Prochlorperazine—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000121	0.0012	CcSEcCtD
Prochlorperazine—Pruritus—Zoledronate—osteoporosis	0.00012	0.00119	CcSEcCtD
Prochlorperazine—Insomnia—Estradiol—osteoporosis	0.000119	0.00118	CcSEcCtD
Prochlorperazine—Rash—Pamidronate—osteoporosis	0.000117	0.00117	CcSEcCtD
Prochlorperazine—Dermatitis—Pamidronate—osteoporosis	0.000117	0.00116	CcSEcCtD
Prochlorperazine—Dyspnoea—Estradiol—osteoporosis	0.000117	0.00116	CcSEcCtD
Prochlorperazine—Headache—Pamidronate—osteoporosis	0.000117	0.00116	CcSEcCtD
Prochlorperazine—Somnolence—Estradiol—osteoporosis	0.000117	0.00116	CcSEcCtD
Prochlorperazine—Pruritus—Conjugated Estrogens—osteoporosis	0.000116	0.00115	CcSEcCtD
Prochlorperazine—Dizziness—Zoledronate—osteoporosis	0.000113	0.00112	CcSEcCtD
Prochlorperazine—Constipation—Estradiol—osteoporosis	0.000112	0.00111	CcSEcCtD
Prochlorperazine—Dizziness—Conjugated Estrogens—osteoporosis	0.000108	0.00107	CcSEcCtD
Prochlorperazine—Rash—Zoledronate—osteoporosis	0.000107	0.00106	CcSEcCtD
Prochlorperazine—Dermatitis—Zoledronate—osteoporosis	0.000107	0.00106	CcSEcCtD
Prochlorperazine—Headache—Zoledronate—osteoporosis	0.000107	0.00106	CcSEcCtD
Prochlorperazine—Urticaria—Estradiol—osteoporosis	0.000104	0.00103	CcSEcCtD
Prochlorperazine—Body temperature increased—Estradiol—osteoporosis	0.000104	0.00103	CcSEcCtD
Prochlorperazine—Rash—Conjugated Estrogens—osteoporosis	0.000103	0.00102	CcSEcCtD
Prochlorperazine—Dermatitis—Conjugated Estrogens—osteoporosis	0.000103	0.00102	CcSEcCtD
Prochlorperazine—Headache—Conjugated Estrogens—osteoporosis	0.000103	0.00102	CcSEcCtD
Prochlorperazine—Hypersensitivity—Estradiol—osteoporosis	9.66e-05	0.000958	CcSEcCtD
Prochlorperazine—Pruritus—Estradiol—osteoporosis	9.28e-05	0.00092	CcSEcCtD
Prochlorperazine—Dizziness—Estradiol—osteoporosis	8.67e-05	0.00086	CcSEcCtD
Prochlorperazine—Rash—Estradiol—osteoporosis	8.27e-05	0.00082	CcSEcCtD
Prochlorperazine—Dermatitis—Estradiol—osteoporosis	8.26e-05	0.000819	CcSEcCtD
Prochlorperazine—Headache—Estradiol—osteoporosis	8.22e-05	0.000815	CcSEcCtD
Prochlorperazine—HRH1—GPCR downstream signaling—PTHLH—osteoporosis	6.48e-07	0.0015	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—MGLL—osteoporosis	6.46e-07	0.00149	CbGpPWpGaD
Prochlorperazine—CHRM2—SIDS Susceptibility Pathways—TNF—osteoporosis	6.42e-07	0.00148	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling by GPCR—WNT1—osteoporosis	6.4e-07	0.00148	CbGpPWpGaD
Prochlorperazine—CHRM2—GPCR downstream signaling—PTHLH—osteoporosis	6.38e-07	0.00147	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—MGLL—osteoporosis	6.34e-07	0.00146	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—LRP5—osteoporosis	6.31e-07	0.00146	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—PKM—osteoporosis	6.27e-07	0.00145	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—FDPS—osteoporosis	6.27e-07	0.00145	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—MGLL—osteoporosis	6.24e-07	0.00144	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—LRP5—osteoporosis	6.19e-07	0.00143	CbGpPWpGaD
Prochlorperazine—HTR2C—GPCR ligand binding—POMC—osteoporosis	6.1e-07	0.00141	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—LRP5—osteoporosis	6.09e-07	0.00141	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—LRP6—osteoporosis	6.03e-07	0.00139	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling by GPCR—PTHLH—osteoporosis	5.99e-07	0.00138	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling by GPCR—CALCA—osteoporosis	5.98e-07	0.00138	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—PGLS—osteoporosis	5.95e-07	0.00137	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—GPD2—osteoporosis	5.95e-07	0.00137	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—LRP6—osteoporosis	5.92e-07	0.00137	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling by GPCR—PTHLH—osteoporosis	5.89e-07	0.00136	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—LRP6—osteoporosis	5.83e-07	0.00135	CbGpPWpGaD
Prochlorperazine—DRD2—GPCR downstream signaling—CALCA—osteoporosis	5.81e-07	0.00134	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling by GPCR—PTHLH—osteoporosis	5.79e-07	0.00134	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—TLN1—osteoporosis	5.77e-07	0.00133	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—P4HB—osteoporosis	5.74e-07	0.00132	CbGpPWpGaD
Prochlorperazine—DRD3—Circadian rythm related genes—IL6—osteoporosis	5.72e-07	0.00132	CbGpPWpGaD
Prochlorperazine—HRH1—GPCR downstream signaling—CALCA—osteoporosis	5.71e-07	0.00132	CbGpPWpGaD
Prochlorperazine—CHRM2—GPCR downstream signaling—CALCA—osteoporosis	5.61e-07	0.0013	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—PTH—osteoporosis	5.58e-07	0.00129	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—RAP1A—osteoporosis	5.49e-07	0.00127	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—CNR2—osteoporosis	5.44e-07	0.00126	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—ATIC—osteoporosis	5.44e-07	0.00126	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—PNP—osteoporosis	5.44e-07	0.00126	CbGpPWpGaD
Prochlorperazine—DRD3—GPCR downstream signaling—ADCY5—osteoporosis	5.4e-07	0.00125	CbGpPWpGaD
Prochlorperazine—DRD2—GPCR ligand binding—POMC—osteoporosis	5.38e-07	0.00124	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—NFATC1—osteoporosis	5.35e-07	0.00124	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—DKK1—osteoporosis	5.31e-07	0.00123	CbGpPWpGaD
Prochlorperazine—HRH1—GPCR ligand binding—POMC—osteoporosis	5.28e-07	0.00122	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling by GPCR—CALCA—osteoporosis	5.28e-07	0.00122	CbGpPWpGaD
Prochlorperazine—CHRM2—GPCR ligand binding—POMC—osteoporosis	5.2e-07	0.0012	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling by GPCR—CALCA—osteoporosis	5.18e-07	0.0012	CbGpPWpGaD
Prochlorperazine—CHRM2—SIDS Susceptibility Pathways—IL6—osteoporosis	5.18e-07	0.00119	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—WNT1—osteoporosis	5.12e-07	0.00118	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling by GPCR—CALCA—osteoporosis	5.1e-07	0.00118	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—TLN1—osteoporosis	5.09e-07	0.00118	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—TLN1—osteoporosis	5e-07	0.00115	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—FGA—osteoporosis	4.98e-07	0.00115	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—P4HB—osteoporosis	4.98e-07	0.00115	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—TLN1—osteoporosis	4.92e-07	0.00114	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling by GPCR—ADCY5—osteoporosis	4.91e-07	0.00113	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—PTH—osteoporosis	4.84e-07	0.00112	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—RAP1A—osteoporosis	4.76e-07	0.0011	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—CNR2—osteoporosis	4.72e-07	0.00109	CbGpPWpGaD
Prochlorperazine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—osteoporosis	4.7e-07	0.00108	CbGpPWpGaD
Prochlorperazine—HTR2C—GPCR downstream signaling—ADCY5—osteoporosis	4.68e-07	0.00108	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—NFATC1—osteoporosis	4.64e-07	0.00107	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—PTHLH—osteoporosis	4.63e-07	0.00107	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—BMP2—osteoporosis	4.63e-07	0.00107	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—CA2—osteoporosis	4.63e-07	0.00107	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—OXCT1—osteoporosis	4.63e-07	0.00107	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—DKK1—osteoporosis	4.61e-07	0.00106	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—FGB—osteoporosis	4.53e-07	0.00105	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—MGLL—osteoporosis	4.51e-07	0.00104	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—WNT1—osteoporosis	4.44e-07	0.00102	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—P4HB—osteoporosis	4.39e-07	0.00101	CbGpPWpGaD
Prochlorperazine—DRD2—Circadian rythm related genes—IL6—osteoporosis	4.38e-07	0.00101	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—PSMA5—osteoporosis	4.37e-07	0.00101	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—PSMA2—osteoporosis	4.37e-07	0.00101	CbGpPWpGaD
Prochlorperazine—CYP3A4—Biological oxidations—POMC—osteoporosis	4.35e-07	0.001	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—FGA—osteoporosis	4.32e-07	0.000996	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—P4HB—osteoporosis	4.31e-07	0.000995	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—PTH—osteoporosis	4.27e-07	0.000986	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling by GPCR—ADCY5—osteoporosis	4.25e-07	0.000982	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—P4HB—osteoporosis	4.24e-07	0.000979	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—RAP1A—osteoporosis	4.2e-07	0.000969	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—PTH—osteoporosis	4.2e-07	0.000968	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—CNR2—osteoporosis	4.16e-07	0.000961	CbGpPWpGaD
Prochlorperazine—DRD2—GPCR downstream signaling—ADCY5—osteoporosis	4.13e-07	0.000954	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—PTH—osteoporosis	4.13e-07	0.000953	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—RAP1A—osteoporosis	4.12e-07	0.000952	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—FDPS—osteoporosis	4.1e-07	0.000947	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—PKM—osteoporosis	4.1e-07	0.000947	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—NFATC1—osteoporosis	4.1e-07	0.000945	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—CNR2—osteoporosis	4.09e-07	0.000944	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—CALCA—osteoporosis	4.07e-07	0.00094	CbGpPWpGaD
Prochlorperazine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—osteoporosis	4.07e-07	0.000939	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—DKK1—osteoporosis	4.06e-07	0.000938	CbGpPWpGaD
Prochlorperazine—HRH1—GPCR downstream signaling—ADCY5—osteoporosis	4.06e-07	0.000937	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—RAP1A—osteoporosis	4.06e-07	0.000936	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—CNR2—osteoporosis	4.02e-07	0.000928	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—NFATC1—osteoporosis	4.02e-07	0.000928	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—BMP2—osteoporosis	4.01e-07	0.000926	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—PTHLH—osteoporosis	4.01e-07	0.000926	CbGpPWpGaD
Prochlorperazine—CHRM2—GPCR downstream signaling—ADCY5—osteoporosis	3.99e-07	0.000922	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—DKK1—osteoporosis	3.99e-07	0.000921	CbGpPWpGaD
Prochlorperazine—DRD3—GPCR downstream signaling—POMC—osteoporosis	3.97e-07	0.000917	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—NFATC1—osteoporosis	3.96e-07	0.000913	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—DKK1—osteoporosis	3.93e-07	0.000906	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—FGB—osteoporosis	3.93e-07	0.000906	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—WNT1—osteoporosis	3.92e-07	0.000904	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—GPD2—osteoporosis	3.89e-07	0.000898	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—PGLS—osteoporosis	3.89e-07	0.000898	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—WNT1—osteoporosis	3.84e-07	0.000887	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—IDH2—osteoporosis	3.83e-07	0.000885	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—FGA—osteoporosis	3.81e-07	0.000879	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—PSMA2—osteoporosis	3.79e-07	0.000875	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—PSMA5—osteoporosis	3.79e-07	0.000875	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—WNT1—osteoporosis	3.78e-07	0.000873	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling by GPCR—ADCY5—osteoporosis	3.75e-07	0.000866	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—FGA—osteoporosis	3.74e-07	0.000863	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—KL—osteoporosis	3.7e-07	0.000854	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling by GPCR—ADCY5—osteoporosis	3.69e-07	0.00085	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—FGA—osteoporosis	3.68e-07	0.000849	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling by GPCR—ADCY5—osteoporosis	3.63e-07	0.000837	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling by GPCR—POMC—osteoporosis	3.61e-07	0.000833	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—CYP27A1—osteoporosis	3.6e-07	0.000832	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—PNP—osteoporosis	3.56e-07	0.000821	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—ATIC—osteoporosis	3.56e-07	0.000821	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—PTHLH—osteoporosis	3.54e-07	0.000817	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—BMP2—osteoporosis	3.54e-07	0.000817	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—CALCA—osteoporosis	3.53e-07	0.000815	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling by GPCR—IL6R—osteoporosis	3.52e-07	0.000812	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—ACP5—osteoporosis	3.51e-07	0.000809	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—BMP2—osteoporosis	3.48e-07	0.000802	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—PTHLH—osteoporosis	3.48e-07	0.000802	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—FGB—osteoporosis	3.47e-07	0.0008	CbGpPWpGaD
Prochlorperazine—HTR2C—GPCR downstream signaling—POMC—osteoporosis	3.44e-07	0.000795	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—PTHLH—osteoporosis	3.42e-07	0.000789	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—BMP2—osteoporosis	3.42e-07	0.000789	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—FGB—osteoporosis	3.4e-07	0.000785	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—FGB—osteoporosis	3.35e-07	0.000773	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—PSMA2—osteoporosis	3.35e-07	0.000772	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—PSMA5—osteoporosis	3.35e-07	0.000772	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—PSMA2—osteoporosis	3.28e-07	0.000758	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—PSMA5—osteoporosis	3.28e-07	0.000758	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—TPI1—osteoporosis	3.26e-07	0.000752	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—PSMA5—osteoporosis	3.23e-07	0.000746	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—PSMA2—osteoporosis	3.23e-07	0.000746	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—KL—osteoporosis	3.21e-07	0.00074	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling by GPCR—POMC—osteoporosis	3.13e-07	0.000722	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—CALCA—osteoporosis	3.12e-07	0.000719	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—P4HB—osteoporosis	3.06e-07	0.000707	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—CALCA—osteoporosis	3.06e-07	0.000706	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling by GPCR—IL6R—osteoporosis	3.05e-07	0.000704	CbGpPWpGaD
Prochlorperazine—DRD2—GPCR downstream signaling—POMC—osteoporosis	3.04e-07	0.000702	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—OXCT1—osteoporosis	3.02e-07	0.000698	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—CA2—osteoporosis	3.02e-07	0.000698	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—CALCA—osteoporosis	3.01e-07	0.000695	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—GAPDH—osteoporosis	3.01e-07	0.000694	CbGpPWpGaD
Prochlorperazine—HRH1—GPCR downstream signaling—POMC—osteoporosis	2.99e-07	0.000689	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—MGLL—osteoporosis	2.95e-07	0.00068	CbGpPWpGaD
Prochlorperazine—CHRM2—GPCR downstream signaling—POMC—osteoporosis	2.94e-07	0.000678	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—RAP1A—osteoporosis	2.93e-07	0.000676	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—ADCY5—osteoporosis	2.9e-07	0.000669	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—KL—osteoporosis	2.83e-07	0.000653	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—SPP1—osteoporosis	2.8e-07	0.000647	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—KL—osteoporosis	2.78e-07	0.000641	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling by GPCR—POMC—osteoporosis	2.76e-07	0.000637	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—KL—osteoporosis	2.73e-07	0.000631	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling by GPCR—POMC—osteoporosis	2.71e-07	0.000626	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling by GPCR—IL6R—osteoporosis	2.69e-07	0.000622	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling by GPCR—POMC—osteoporosis	2.67e-07	0.000616	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling by GPCR—IL6R—osteoporosis	2.64e-07	0.00061	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling by GPCR—IL6R—osteoporosis	2.6e-07	0.0006	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—IRS2—osteoporosis	2.54e-07	0.000585	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—ADCY5—osteoporosis	2.51e-07	0.00058	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—IDH2—osteoporosis	2.51e-07	0.000578	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—LEP—osteoporosis	2.48e-07	0.000573	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—SPP1—osteoporosis	2.43e-07	0.000561	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—ESR1—osteoporosis	2.37e-07	0.000547	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—ENO1—osteoporosis	2.37e-07	0.000547	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—CYP27A1—osteoporosis	2.36e-07	0.000544	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—PSMA2—osteoporosis	2.33e-07	0.000539	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—PSMA5—osteoporosis	2.33e-07	0.000539	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—ACP5—osteoporosis	2.29e-07	0.000529	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—ADCY5—osteoporosis	2.22e-07	0.000512	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—IRS1—osteoporosis	2.21e-07	0.000511	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—IRS2—osteoporosis	2.2e-07	0.000507	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—ADCY5—osteoporosis	2.18e-07	0.000502	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—LEP—osteoporosis	2.15e-07	0.000496	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—SPP1—osteoporosis	2.15e-07	0.000495	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—ADCY5—osteoporosis	2.14e-07	0.000494	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—POMC—osteoporosis	2.13e-07	0.000492	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—TPI1—osteoporosis	2.13e-07	0.000492	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—SPP1—osteoporosis	2.11e-07	0.000486	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—IL6R—osteoporosis	2.08e-07	0.00048	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—SPP1—osteoporosis	2.07e-07	0.000478	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—ESR1—osteoporosis	2.05e-07	0.000474	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—IGF1—osteoporosis	2.05e-07	0.000473	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—P4HB—osteoporosis	2e-07	0.000462	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—GAPDH—osteoporosis	1.97e-07	0.000454	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—IRS2—osteoporosis	1.94e-07	0.000448	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—IRS1—osteoporosis	1.92e-07	0.000443	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—RAP1A—osteoporosis	1.92e-07	0.000442	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—IRS2—osteoporosis	1.9e-07	0.00044	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—LEP—osteoporosis	1.9e-07	0.000438	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—CYP19A1—osteoporosis	1.89e-07	0.000437	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—IRS2—osteoporosis	1.87e-07	0.000433	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—LEP—osteoporosis	1.86e-07	0.00043	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—POMC—osteoporosis	1.85e-07	0.000426	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—LEP—osteoporosis	1.83e-07	0.000423	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—ESR1—osteoporosis	1.81e-07	0.000418	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—IL6R—osteoporosis	1.8e-07	0.000416	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—ESR1—osteoporosis	1.78e-07	0.000411	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—IGF1—osteoporosis	1.78e-07	0.00041	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—ESR1—osteoporosis	1.75e-07	0.000404	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—IRS1—osteoporosis	1.69e-07	0.000391	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—IRS1—osteoporosis	1.66e-07	0.000384	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—IRS1—osteoporosis	1.64e-07	0.000378	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—POMC—osteoporosis	1.63e-07	0.000376	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—POMC—osteoporosis	1.6e-07	0.00037	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—IL6R—osteoporosis	1.59e-07	0.000367	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—POMC—osteoporosis	1.58e-07	0.000364	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—IGF1—osteoporosis	1.57e-07	0.000362	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling by GPCR—IL6—osteoporosis	1.57e-07	0.000362	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—IL6R—osteoporosis	1.56e-07	0.00036	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—ENO1—osteoporosis	1.55e-07	0.000357	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—ADCY5—osteoporosis	1.55e-07	0.000357	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—GPX1—osteoporosis	1.54e-07	0.000356	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—IGF1—osteoporosis	1.54e-07	0.000355	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—IL6R—osteoporosis	1.54e-07	0.000355	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—PSMA2—osteoporosis	1.53e-07	0.000352	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—PSMA5—osteoporosis	1.53e-07	0.000352	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—IGF1—osteoporosis	1.52e-07	0.00035	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—MTHFR—osteoporosis	1.42e-07	0.000328	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling by GPCR—IL6—osteoporosis	1.36e-07	0.000314	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—CYP19A1—osteoporosis	1.24e-07	0.000286	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—MYC—osteoporosis	1.23e-07	0.000284	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—TGFB1—osteoporosis	1.23e-07	0.000284	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling by GPCR—IL6—osteoporosis	1.2e-07	0.000277	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling by GPCR—IL6—osteoporosis	1.18e-07	0.000272	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling by GPCR—IL6—osteoporosis	1.16e-07	0.000267	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—POMC—osteoporosis	1.14e-07	0.000263	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—MYC—osteoporosis	1.07e-07	0.000247	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—TGFB1—osteoporosis	1.07e-07	0.000246	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—ADCY5—osteoporosis	1.01e-07	0.000233	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—GPX1—osteoporosis	1.01e-07	0.000233	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—MYC—osteoporosis	9.43e-08	0.000218	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—TGFB1—osteoporosis	9.41e-08	0.000217	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—MTHFR—osteoporosis	9.3e-08	0.000215	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—IL6—osteoporosis	9.26e-08	0.000214	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—MYC—osteoporosis	9.26e-08	0.000214	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—TGFB1—osteoporosis	9.23e-08	0.000213	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—MYC—osteoporosis	9.11e-08	0.00021	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—TGFB1—osteoporosis	9.09e-08	0.00021	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—IL6—osteoporosis	8.03e-08	0.000185	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—POMC—osteoporosis	7.44e-08	0.000172	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—IL6—osteoporosis	7.09e-08	0.000164	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—IL6—osteoporosis	6.96e-08	0.000161	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—IL6—osteoporosis	6.85e-08	0.000158	CbGpPWpGaD
